Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polycythemia Vera × Erlotinib Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 130 Lung Neoplasms 54 Pancreatic Neoplasms 32 Neoplasms 17 Breast Neoplasms 13 Neoplasm Metastasis 12 Brain Neoplasms 12 Adenocarcinoma of Lung 12 Glioblastoma 11 Gliosarcoma 10 Adenocarcinoma, Bronchiolo-Alveolar 10 Non-Squamous Non-Small Cell Lung Cancer 9 Carcinoma, Hepatocellular 9 Squamous Cell Carcinoma of Head and Neck 8 Head and Neck Neoplasms 8 Carcinoma, Renal Cell 8 Colorectal Neoplasms 7 Esophageal Neoplasms 6 Urinary Bladder Neoplasms 5 Gallbladder Neoplasms 5 Carcinoma, Squamous Cell 5 Ovarian Neoplasms 4 Kidney Neoplasms 4 Fallopian Tube Neoplasms 4 Colonic Neoplasms 4 Central Nervous System Neoplasms 4 Bile Duct Neoplasms 4 Adenocarcinoma Of Esophagus 4 Adenocarcinoma 4 Recurrence 3

Interventions

fludarabine phosphate 17 Cyclophosphamide 15 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 10 ruxolitinib 9 Mycophenolic Acid 9 Busulfan 9 Tacrolimus 8 fludarabine 7 Radiotherapy 5 Methotrexate 5 Cyclosporine 5 Aspirin 5 Melphalan 4 Imatinib Mesylate 4 Biopsy 4 Antilymphocyte Serum 4 peginterferon alfa-2a 3 givinostat hydrochloride 3 givinostat 3 Stem Cell Transplantation 3 Specimen Handling 3 Prednisone 3 Decitabine 3 bomedemstat 2 Surveys and Questionnaires 2 Methylprednisolone 2 Lenalidomide 2 Filgrastim 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01038856 2020-08-24

OSI-TAR-766

University of Oklahoma

Phase 2 Terminated

5 enrolled 6 charts

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡